Rchr
J-GLOBAL ID:201801015565134057   Update date: Oct. 10, 2024

Takashi Yoshioka

Takashi Yoshioka
Affiliation and department:
Research field  (3): Healthcare management, medical sociology ,  Healthcare management, medical sociology ,  Urology
Research keywords  (9): タバコ対策 ,  医療政策 ,  医療経済評価 ,  Lower Urinary Tract Symptoms ,  Healthy Aging ,  Clinical Prediction Rules ,  urologic oncology ,  renal transplantation ,  urolithiasis
Research theme for competitive and other funds  (4):
  • 2024 - 2025 Association between industry sponsorship and methodology of health economic evaluation studies of anticancer drugs.
  • 2022 - 2025 がん患者の社会経済状況に関する医療経済学的検討
  • 2021 - 2024 Development and validation of the EQ-5D-5L value set among Japanese older adults for health technology assessment
  • 2017 - 2019 Development and Validation of Prediction Model using Computed Tomography (CT) Information for Shock Wave Lithotripsy Failure of Upper Urinary Tract Calculi.
Papers (35):
  • Satoshi Funada, Yan Luo, Hirotaka Kato, Takashi Yoshioka, Shunsuke Uno, Kimiko Honda, Yoko Akune, Rei Goto. Trends in the integration of medical corporation hospitals in Japan: a national wide longitudinal study between 2017 and 2021. BMC health services research. 2024. 24. 1. 1005-1005
  • Takashi Yoshioka, Ryuhei So, Satoshi Funada, Shiori Tsutsumi, Tomoki Nakaya, Ryo Okubo, Tetsuji Minami, Takahiro Tabuchi. Association of night-shift work with gambling and problem gambling among workers in Japan: A nationwide cross-sectional study. Addictive behaviors. 2024. 156. 108071-108071
  • Tomomi Maeda, Kensuke Moriwaki, Kosuke Morimoto, Xiuting Mo, Takashi Yoshioka, Rei Goto, Kojiro Shimozuma. Cost-effectiveness Analysis of Nivolumab Plus Ipilimumab Combination Therapy as First-line Treatment for Advanced Renal Cell Carcinoma in Japan. Value in health regional issues. 2024. 40. 118-126
  • Satoshi Funada, Takashi Yoshioka, Yan Luo, Akira Sato, Shusuke Akamatsu, Norio Watanabe. Bladder training for treating overactive bladder in adults. The Cochrane database of systematic reviews. 2023. 10. 10. CD013571
  • Satoshi Funada, Takashi Yoshioka, Yan Luo, Toshi Iwama, Chikako Mori, Naofumi Yamada, Hideki Yoshida, Kota Katanoda, Toshi A Furukawa. Global Trends in Highly Cited Studies in COVID-19 Research. JAMA network open. 2023. 6. 9. e2332802
more...
MISC (69):
  • Takashi Yoshioka, Kenji Omae, Satoshi Funada, Tetsuji Minami, Rei Goto. Health Utility Value of Overactive Bladder in Japanese Older Adults. 2024
  • Yuya Ando, Takashi Yoshioka, Kazuyuki Narimatsu. Comment on "Predicting the risk stratification of gastrointestinal stromal tumors using machine learning-based ultrasound radiomics". Journal of medical ultrasonics (2001). 2024. 51. 2. 375-375
  • Fumihiko Urabe, Takashi Yoshioka, Kojiro Tashiro, Takahiro Kimura. Letter: Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial. The Journal of urology. 2024. 101097JU0000000000003873
  • Mayumi Terada, Keiya Kanno, Hiroto Tamura, Jun Miyata, Takashi Yoshioka, Tetsuro Aita. Is Short-Term Antimicrobial Administration Sufficient? The Need for Considering Information on Infection-Related Variables and the Target Population. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024
  • Fumihiko Urabe, Takashi Yoshioka, Takahiro Kimura. Re: Felix Seelemeyer, David Pfister, Robert Pappesch, et al. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021. European urology oncology. 2024. 7. 2. 307-307
more...
Books (1):
  • Medical Treatment Up To Date Japanese Edition
    Japan Medical Journal 2017
Lectures and oral presentations  (10):
  • The present and future of urolithiasis through the lens of society: pe rspectives from epidemiology, public health, and health economics
    (The 111th Annual Meeting of the Japanese Urological Association 2024)
  • 日本のデータベース研究を ハイインパクトジャーナルに 載せるために: 成功事例の紹介と吟味
    (日本臨床疫学会 第6回年次学術大会 2023)
  • はじまりはいつもletter: 執筆ノススメ
    (日本臨床疫学会 第6回年次学術大会 2023)
  • プライマリ・ケア専門職のためのletter to the editor書き方講座
    (PCR Connect the 4th 2022)
  • 医療経済評価研究ことはじめ: 先ず分析枠組みより始めよ
    (日本臨床疫学会 第5回年次学術大会 2022)
more...
Education (4):
  • 2021 - 2022 Keio University
  • 2016 - 2018 Kyoto University Graduate School of Public Health in the Graduate School of Medicine Department of Healthcare Epidemiology
  • 2012 - 2016 Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Department of Urology
  • 2004 - 2010 Okayama University Medical School
Work history (7):
  • 2024/04 - 現在 Showa University Institute of Clinical Epidemiology
  • 2023/11 - 現在 Keio University School of Medicine Department of Preventive Medicine and Public Health
  • 2023/04 - 現在 Shizuoka Graduate University of Public Health
  • 2022/04 - 2023/11 Keio University School of Medicine Department of Preventive Medicine and Public Health
  • 2017/04 - 2022/04 Fukushima Medical University Center for Innovative Research for Communities and Clinical Excellence (CiRC2LE) Assistant Professor
Show all
Committee career (3):
  • 2021/09 - 現在 独立行政法人医薬品医療機器総合機構 新型コロナウイルスワクチン 副反応評価委員
  • 2021/04 - 現在 日本臨床栄養代謝学会 がん患者のための代謝・栄養管理ガイドライン 医療経済評価支援委員
  • 2021/04 - 現在 日本泌尿器科学会 前立腺がん診療ガイドライン 系統的レビュー支援委員
Awards (2):
  • 2021/10 - 日本臨床疫学会 第4回学術集会 優秀演題 (専門家部門) 著名人の白血病公表に伴う日本の骨髄ドナー登録の動向: イベント・スタディ分析
  • 2018/03 - Kyoto University Graduate School of Public Health in the Graduate School of Medicine The excellence award
Association Membership(s) (8):
JAPANESE SOCIETY OF GERIATRIC UROLOGY ,  SOCIETY FOR CLINICAL EPIDEMIOLOGY ,  JAPAN EPIDEMIOLOGICAL ASSOCIATION ,  THE JAPAN SOCIETY FOR TRANSPLANTATION ,  JAPANESE SOCIETY OF ENDOUROLOGY ,  THE JAPANESE SOCIETY OF UROLITHIASIS RESEARCH ,  THE JAPANESE UROLOGICAL ASSOCIATION ,  医療経済学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page